BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 3895999)

  • 1. Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia.
    Espinal CA; Cortes GT; Guerra P; Arias AE
    Am J Trop Med Hyg; 1985 Jul; 34(4):675-80. PubMed ID: 3895999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea.
    Benito A; Roche J; Molina R; Amela C; Alvar J
    Am J Trop Med Hyg; 1995 Nov; 53(5):526-31. PubMed ID: 7485712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan].
    Yang H; Yang P; Yang Y
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1994; 12(2):140-2. PubMed ID: 7955166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
    Ghosh SK; Yadav RS; Sharma VP
    Indian J Malariol; 1992 Dec; 29(4):211-8. PubMed ID: 1291342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia.
    Baird JK; Basri H; Jones TR; Purnomo ; Bangs MJ; Ritonga A
    Am J Trop Med Hyg; 1991 Jun; 44(6):640-4. PubMed ID: 1858967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance of Plasmodium falciparum to 3 antimalarials in Turbo (Antioquia, Colombia), 1998].
    Blair S; Lacharme LL; Fonseca JC; Tobón A
    Rev Panam Salud Publica; 2001 Jan; 9(1):23-9. PubMed ID: 11253274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chloroquine, amodiaquine and pyrimethamine-sulfadoxine on Plasmodium falciparum gametocytemia.
    Strickland GT; Fox E; Sarwar M; Khaliq AA; Macdonald M
    Am J Trop Med Hyg; 1986 Mar; 35(2):259-62. PubMed ID: 3513644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
    Del Nero L; Lamizana L; Pietra V; Nebié I
    Parassitologia; 1994 Dec; 36(3):287-93. PubMed ID: 7637999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
    Kamugisha J; Kipp W; Burnham G
    Trop Geogr Med; 1994; 46(6):364-5. PubMed ID: 7892705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of resistance to chloroquine, quinine, amodiaquine and mefloquine among Philippine strains of Plasmodium falciparum.
    Smrkovski LL; Buck RL; Alcantara AK; Rodriguez CS; Uylangco CV
    Trans R Soc Trop Med Hyg; 1985; 79(1):37-41. PubMed ID: 3887681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Falciparum malaria resistant to chloroquine, quinine and Fansidar in a non-immune patient infected in Ghana.
    Nguyen C; Gregson D; Mouldey P; Keystone JS
    Trans R Soc Trop Med Hyg; 1989; 83(4):485-6. PubMed ID: 2694485
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vitro activity of various antimalarials (chloroquine, amodiaquine, quinine and mefloquine) against 32 isolates of Plasmodium falciparum in French Guiana].
    Dedet JP; Germanetto P; Cordoliani G; Bonnevie O; Le Bras J
    Bull Soc Pathol Exot Filiales; 1988; 81(1):88-93. PubMed ID: 3042179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of Plamodium falciparum to antimalarial drugs in Zaragoza (Antioquia, Colombia), 1998.
    Blair-Trujillo S; Lacharme-Lora L; Carmona-Fonseca J
    Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):401-6. PubMed ID: 12048572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Plasmodium falciparum in vitro to chloroquine, mefloquine, quinine and sulfadoxine/pyrimethamine in Somalia: relationships between the responses to the different drugs.
    Warsame M; Wernsdorfer WH; Payne D; Björkman A
    Trans R Soc Trop Med Hyg; 1991; 85(5):565-9. PubMed ID: 1780976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amodiaquine fails to cure chloroquine resistant Plasmodium falciparum in the Punjab.
    Khaliq AA; Fox E; Sarwar M; Strickland GT
    Trans R Soc Trop Med Hyg; 1987; 81(1):157-9. PubMed ID: 3328330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Plasmodium falciparum to five drugs: an in vitro study of isolates mainly from Thailand.
    Thaithong S; Beale GH; Chutmongkonkul M
    Trans R Soc Trop Med Hyg; 1983; 77(2):228-31. PubMed ID: 6346591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro study assessing the response of plasmodium falciparum malaria to chloroquine, sulfadoxine/pyrimethamine, quinine and mefloquine in Wad Medani District, Sudan.
    Nour BY; Faragalla IA; Saeed OK; Mohamadani AA
    Saudi Med J; 2006 Jun; 27(6):808-12. PubMed ID: 16758040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
    Hoffman SL; Rustama D; Dimpudus AJ; Punjabi NH; Campbell JR; Oetomo HS; Marwoto HA; Harun S; Sukri N; Heizmann P
    Lancet; 1985 Nov; 2(8463):1039-40. PubMed ID: 2865518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.